Burzynski Research Institute Inc BZYR:OTCPK

RT Quote | Exchange | USD
Last | 05/17/22 EDT
0.015UNCH (UNCH)
52 week range
0.01 - 0.05
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.015
  • 52 Week High0.05
  • 52 Week High Date04/01/22
  • 52 Week Low0.01
  • 52 Week Low Date12/31/21

Key Stats

  • Market Cap1.97M
  • Shares Out131.45M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.07
  • YTD % Change25

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.015
  • 52 Week High0.05
  • 52 Week High Date04/01/22
  • 52 Week Low0.01
  • 52 Week Low Date12/31/21
  • Market Cap1.97M
  • Shares Out131.45M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.07
  • YTD % Change25

RATIOS/PROFITABILITY

  • EPS (TTM)-0.01
  • P/E (TTM)-2.05
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-1.057M
  • ROE (TTM)-
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Burzynski Research Institute Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Burzynski Research Institute, Inc. is engaged in the research, production, marketing, promotion and sale of certain medical chemical compounds. The chemical compounds are composed of growth-inhibiting peptides, amino acid derivatives and organic acids, which are known under the trade name Antineoplastons. Antineoplastons are found in the bodily fluids of humans and food. The Company is primarily engaged as a research and development facility of drugs being tested for the use...
Stanislaw Burzynski M.D., Ph.D.
Chairman of the Board, President
Tomasz Janicki M.D.
Vice President - Clinical Trials
Address
12000 Richmond Ave
Houston, TX
77082
United States